Low Levels of Estradiol Are Associated with Vertebral Fractures in Older Men, But Not Women: The Rancho Bernardo Study1
Elizabeth Barrett-Connor,
Judith E. Mueller,
Denise G. von Mühlen,
Gail A. Laughlin,
Diane L. Schneider and
David J. Sartoris
Department of Family and Preventive Medicine, Division of
Epidemiology (E.B.-C., D.G.v.M., G.A.L., D.L.S., D.J.S.), School of
Medicine, University of CaliforniaSan Diego, La Jolla, California
92093-0607; and Department of Obstetrics and Gynecology (J.E.M.),
Technische Universität München, D-81675 Munich,
Germany
Address correspondence and requests for reprints to: Dr. Elizabeth Barrett-Connor, Division of Epidemiology, School of Medicine, University of CaliforniaSan Diego, 9500 Gilman Drive, Department 0607, La Jolla, California 92093-0607.
This longitudinal study included 288 postmenopausal women without
estrogenuse (median age, 72 yr) and 352 men (median age, 66 yr). All
werecommunity-dwelling, ambulatory, and Caucasian. Blood for hormone
assays(total and bioavailable estradiol and testosterone, estrone,
androstenedione,dihydrotestosterone, dehydroepiandrosterone, and
dehydroepiandrosteronesulfate) was obtained in 19841987, and
vertebral fractureswere diagnosed from lateral spine radiographs
obtained in 19921996.At least one vertebral fracture was found in
21% of women and8% of men. Among men, age-adjusted hormone levels
differed byfracture status only for total (64.1 vs.
75.4 pmol/L, P = 0.012)and bioavailable (43.0
vs. 51.4 pmol/L, P = 0.008)
estradiol.There was a graded association between higher concentrations
oftotal and bioavailable estradiol and lower fracture prevalence
(trendP < 0.01 for both hormones). Men with total
testosteronelevels compatible with hypogonadism (<7 nmol/L) were not
morelikely to have vertebral fractures. In women, none of the measured
sexhormones was associated with vertebral fractures. There wasalso no
increased prevalence of fractures in women with estradiollevels below
the assay sensitivity (<11 pmol/L). These datasuggest that estrogen
plays a critical role in the skeletalhealth of older men and confirm
other studies showing no associationof postmenopausal endogenous
estrogen levels with vertebralfractures in older women.
This article has been cited by other articles:
E. S. LeBlanc, C. M. Nielson, L. M. Marshall, J. A. Lapidus, E. Barrett-Connor, K. E. Ensrud, A. R. Hoffman, G. Laughlin, C. Ohlsson, E. S. Orwoll, et al. The Effects of Serum Testosterone, Estradiol, and Sex Hormone Binding Globulin Levels on Fracture Risk in Older Men
J. Clin. Endocrinol. Metab.,
September 1, 2009;
94(9):
3337 - 3346.
[Abstract][Full Text][PDF]
C. Ohlsson and L. Vandenput The role of estrogens for male bone health
Eur. J. Endocrinol.,
June 1, 2009;
160(6):
883 - 889.
[Abstract][Full Text][PDF]
T. G. Travison, A. B. Araujo, T. J. Beck, R. E. Williams, R. V. Clark, B. Z. Leder, and J. B. McKinlay Relation between Serum Testosterone, Serum Estradiol, Sex Hormone-Binding Globulin, and Geometrical Measures of Adult Male Proximal Femur Strength
J. Clin. Endocrinol. Metab.,
March 1, 2009;
94(3):
853 - 860.
[Abstract][Full Text][PDF]
S. Khosla, S. Amin, and E. Orwoll Osteoporosis in Men
Endocr. Rev.,
June 1, 2008;
29(4):
441 - 464.
[Abstract][Full Text][PDF]
C. Meier, T. V. Nguyen, D. J. Handelsman, C. Schindler, M. M. Kushnir, A. L. Rockwood, A. W. Meikle, J. R. Center, J. A. Eisman, and M. J. Seibel Endogenous Sex Hormones and Incident Fracture Risk in Older Men: The Dubbo Osteoporosis Epidemiology Study
Arch Intern Med,
January 14, 2008;
168(1):
47 - 54.
[Abstract][Full Text][PDF]
A. Bjornerem, L. A. Ahmed, R. M. Joakimsen, G. K R. Berntsen, V. Fonnebo, L. Jorgensen, P. Oian, E. Seeman, and B. Straume A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study
Eur. J. Endocrinol.,
July 1, 2007;
157(1):
119 - 125.
[Abstract][Full Text][PDF]
J. A. Riancho, C. Valero, A. Naranjo, D. J. Morales, C. Sanudo, and M. T. Zarrabeitia Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis
J. Clin. Endocrinol. Metab.,
February 1, 2007;
92(2):
660 - 665.
[Abstract][Full Text][PDF]
V. J. Wright Osteoporosis in Men
J. Am. Acad. Ortho. Surg.,
June 1, 2006;
14(6):
347 - 353.
[Abstract][Full Text][PDF]
J. P. Bilezikian What's Good for the Goose's Skeleton is Good for the Gander's Skeleton.
J. Clin. Endocrinol. Metab.,
April 1, 2006;
91(4):
1223 - 1225.
[Full Text][PDF]
V Rochira, A Balestrieri, B Madeo, L Zirilli, A R M Granata, and C Carani Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology
Eur. J. Endocrinol.,
February 1, 2006;
154(2):
175 - 185.
[Abstract][Full Text][PDF]
S. Sipila, E. Heikkinen, S. Cheng, H. Suominen, P. Saari, V. Kovanen, M. Alen, and T. Rantanen Endogenous Hormones, Muscle Strength, and Risk of Fall-Related Fractures in Older Women
J Gerontol A Biol Sci Med Sci,
January 1, 2006;
61(1):
92 - 96.
[Abstract][Full Text][PDF]
J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Endocr. Rev.,
October 1, 2005;
26(6):
833 - 876.
[Abstract][Full Text][PDF]
A. Bjornerem, B. Straume, M. Midtby, V. Fonnebo, J. Sundsfjord, J. Svartberg, G. Acharya, P. Oian, and G. K. R. Berntsen Endogenous Sex Hormones in Relation to Age, Sex, Lifestyle Factors, and Chronic Diseases in a General Population: The Tromso Study
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6039 - 6047.
[Abstract][Full Text][PDF]
P. B. Rapuri, J. C. Gallagher, and G. Haynatzki Endogenous Levels of Serum Estradiol and Sex Hormone Binding Globulin Determine Bone Mineral Density, Bone Remodeling, the Rate of Bone Loss, and Response to Treatment with Estrogen in Elderly Women
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
4954 - 4962.
[Abstract][Full Text][PDF]
H. W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F. H. de Jong, and H. A. P. Pols Endogenous Sex Hormones, Sex Hormone-Binding Globulin, and the Risk of Incident Vertebral Fractures in Elderly Men and Women: The Rotterdam Study
J. Clin. Endocrinol. Metab.,
July 1, 2004;
89(7):
3261 - 3269.
[Abstract][Full Text][PDF]
E. Barrett-Connor and S. Bhasin Time for (More Research on) Testosterone
J. Clin. Endocrinol. Metab.,
February 1, 2004;
89(2):
501 - 502.
[Full Text][PDF]
I. Van Pottelbergh, S. Goemaere, and J. M. Kaufman Bioavailable Estradiol and an Aromatase Gene Polymorphism Are Determinants of Bone Mineral Density Changes in Men over 70 Years of Age
J. Clin. Endocrinol. Metab.,
July 1, 2003;
88(7):
3075 - 3081.
[Abstract][Full Text][PDF]
B. Z. Leder, K. M. LeBlanc, D. A. Schoenfeld, R. Eastell, and J. S. Finkelstein Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
J. Clin. Endocrinol. Metab.,
January 1, 2003;
88(1):
204 - 210.
[Abstract][Full Text][PDF]
S P Tuck and R M Francis Osteoporosis
Postgrad. Med. J.,
September 1, 2002;
78(923):
526 - 532.
[Abstract][Full Text][PDF]
A. J. Kahn and B. Halloran Dehydroepiandrosterone Supplementation and Bone Turnover in Middle-Aged to Elderly Men
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1544 - 1549.
[Abstract][Full Text][PDF]
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men
J Gerontol A Biol Sci Med Sci,
February 1, 2002;
57(2):
M76 - M99.
[Full Text][PDF]
P. J. Snyder Effects of Age on Testicular Function and Consequences of Testosterone Treatment
J. Clin. Endocrinol. Metab.,
June 1, 2001;
86(6):
2369 - 2372.
[Full Text][PDF]
A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation
J. Clin. Endocrinol. Metab.,
June 1, 2001;
86(6):
2380 - 2390.
[Full Text][PDF]
P. Szulc, F. Munoz, B. Claustrat, P. Garnero, F. Marchand, F. Duboeuf, and P. D. Delmas Bioavailable Estradiol May Be an Important Determinant of Osteoporosis in Men: The MINOS Study
J. Clin. Endocrinol. Metab.,
January 1, 2001;
86(1):
192 - 199.
[Abstract][Full Text]